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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.02.066Objective: The radial artery has more smooth muscle in its wall than the other
arterial conduits and is known to be vasospastic. Because it is frequently necessary
to use vasoconstrictors early after coronary bypass surgery we investigated the
effects of phenylephrine on conduit flow in this setting.
Methods: Thirty patients undergoing coronary artery bypass with all arterial con-
duits in which the radial artery was used as a T-graft were randomly assigned to
receive intravenous infusions of normal saline (n  10); nitroglycerin, 0.5 g · kg
· min (n  11); or nicardipine, 0.5 g · kg · min (n  9), beginning early in the
operation. After discontinuation of cardiopulmonary bypass and achievement of
stable hemodynamics, control measurements were obtained, and this was followed
by phenylephrine infusion to achieve a 20% increase in mean arterial pressure, after
which the measurements were repeated.
Results: Mean radial artery flow increased similarly in all groups: normal saline,
40%  25%; nicardipine, 37%  27%; nitroglycerin, 48%  36% (P  .533).
Comparable changes occurred in arterial pressure and systemic vascular resistance,
whereas the cardiac index remained unchanged.
Conclusion: Radial artery blood flow increases when the mean arterial pressure is
increased with phenylephrine. There was no evidence of a conduit vasoconstrictive
effect, which could limit or reduce conduit flow. Vasocontriction with phenyleph-
rine is appropriate to provide adequate perfusion pressure for radial artery grafts.
T he radial artery has had increasing use over the past decade. It has avasospastic tendency noted at harvest, and it has been recommended that itsuse be accompanied by infusion of diltiazem.1,2 In vitro studies demonstrate
that the radial artery contracts more strongly than the internal thoracic artery when
exposed to norepinephrine, serotonin, thromboxane A2 mimetic,3 or endothelin.4
Nitroglycerin (TNG) is a more effective radial artery dilator than is diltiazem.5,6
It is frequently necessary to use vasoconstricting agents immediately after
cardiopulmonary bypass to provide adequate perfusion pressure. Phenylephrine
(PHE), a synthetic sympathomimetic agent chemically related to epinephrine and
ephedrine, is often used for this purpose.
We evaluated the effect of PHE on the flow of the radial artery when used as a
coronary artery bypass conduit in the presence or absence of a vasodilator drug.
Patients and Methods
The study was approved by our institution’s human studies committee, and all patients
provided written informed consent. Thirty adult patients who underwent primary elective
coronary artery bypass grafting with the left internal thoracic artery and the radial artery as
a T-graft7 were studied prospectively. Exclusion criteria included renal, hepatic, or respira-
tory insufficiency; preoperative circulatory support with intra-aortic balloon counterpulsation;
inotropic or vasoactive drug infusion; or allergy to nicardipine (NIC), TNG, or PHE. No
patient was excluded on the basis of preoperative indices of heart function.
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CSPAll patients received their prescribed medications up until the
morning of the operation. Morphine, lorazepam, and scopolamine
in individualized doses were administered as premedication. All
patients received a standardized general endotracheal anesthetic
regimen based on opioids (fentanyl, 0.15-0.20 g/kg) and supple-
mented with midazolam, 5 to 10 mg, and pancuronium. Inhaled
isoflurane was administered at a maximum of 0.4% end-tidal
concentration.
The patients were randomly allocated to 3 groups on the basis
of a computer-generated table of random numbers. After baseline
hemodynamic data had been obtained and before sternal split, one
of the following infusions was started: NIC, 0.5-0.7 g · kg · min;
TNG, 0.5-0.7 g · kg · min; or normal saline 0.9% (NS).
During cardiopulmonary bypass, systemic flows were kept at
greater than 2.4 L · min1 · m2, and mean arterial pressure
(MAP) was maintained between 40 and 80 mm Hg, with pump
flow adjustment and bolus doses of PHE or TNG. Blood gas
analysis was performed every 30 minutes. During bypass, the
patients’ body temperature was kept at 33°C, and blood cardio-
plegia was administered at the same temperature.
At rewarming, after release of the aortic crossclamp, the isoflu-
rane blended into the bypass circuit was switched off, so that at the
time of weaning from bypass, the isoflurane end-tidal concentra-
tion was less than 0.1%. Inotropic support was instituted in those
patients with poor preoperative systolic function, diastolic func-
tion, or both.
The radial artery was harvested without skeletonization. After
conduit harvest, heparin (300 U/kg body weight) was adminis-
tered, and the radial artery was anastomosed to the proximal left
internal thoracic artery (T-graft). Both conduits were filled with
heparinized blood containing papaverine (2 mg/mL) and were
exposed to arterial pressure for 10 minutes during cannulation for
cardiopulmonary bypass. No other graft interventions were at-
tempted. This achieved relaxation of harvest spasm, as confirmed
by means of inspection of conduits and assessment of free flow.
During cardiopulmonary bypass, the left internal thoracic artery
was anastomosed to the left anterior descending coronary artery
and its branches, and the radial artery was anastomosed to the right
coronary artery and/or the circumflex arteries and their branches.
After separation from cardiopulmonary bypass and achieve-
ment of hemodynamic stability, the heart was paced with epicar-
dial atrial leads at 90 beats/min, and the experimental protocol was
carried out. The surgeon measured the blood flow through the
radial artery graft (QRA) by using a calibrated transonic flowmeter
(Transonic Systems Inc, Ithaca, NY) while the anesthesiologist
collected the hemodynamic data (control or pre-PHE measure-
ments). The transonic flowmeter consists of an open ring that is
placed around the grafted radial artery without skeletonization,
distal to the T anastomosis, and proximal to the first distal anas-
tomosis. Then MAP was increased by 20% with infusion of PHE.
After the target MAP was obtained, the above measurements were
repeated (after PHE). To eliminate physician bias and at the same
time to ensure appropriate and ethical clinical care to all patients,
the surgeon was blinded to the patient’s group, as well as the
hemodynamic measurements, and the anesthesiologist was blinded
to the QRA measurements.
The following variables were measured: QRA, MAP, mean
pulmonary artery pressure, central venous pressure, pulmonary
688 The Journal of Thoracic and Cardiovascular Surgery ● Septcapillary wedge pressure, cardiac output in triplicate at end-expi-
ration, and heart rate. Stroke volume (SV), cardiac index, systemic
vascular resistance (SVR), and pulmonary vascular resistance were
calculated by known formulas.
Statistical analysis was performed on Stata 4.0 software (Stata
Corp, College Station, Tex). Categorical (binary) data were com-
pared by the 2 test. Continuous data between groups were com-
pared by analysis of variance with the Bonferroni correction where
necessary. Continuous variables within the same group were com-
pared by the Student t test, assuming where appropriate that the
variance was unequal.
Results
The demographic data, preoperative medications, and car-
diovascular data (history of previous myocardial infarction
and incidence of comorbid diseases, such as diabetes, pre-
vious cerebrovascular events, or smoking) did not differ
among groups (Table 1).
Native coronary artery disease (percentage of obstruc-
tion), as well as the presence or absence of collateral circu-
lation, were similar, both clinically and statistically, among
the participating patients (Table 2). The left anterior de-
scending artery was grafted with the left internal thoracic
artery, and the circumflex and right coronary arteries were
grafted with the radial artery. The number of distal anasto-
moses constructed was not statistically different among the
3 groups. At least 2 distal anastomoses were constructed
with the radial artery in all patients. Inotropic support with
dobutamine, amrinone, or both, was required in a small
number of patients (NIC, 2; NS, 2; TNG, 4; P  .868).
Before PHE administration, the MAP was similar among
the groups, the SVR was lower in the NIC group and higher in
the NS group, and the cardiac output was higher in the NIC
group, whereas the QRA was higher in the TNG group and
lower in the NS group (Table 3). In all groups PHE adminis-
tration resulted in a clinically and statistically significant in-
crease of MAP, SVR, and QRA (Figure 1) in the presence of
unchanged SV (and cardiac index) and right and left heart
filling pressures (Table 3). After PHE, MAP was clinically
similar in all groups, SVR continued to be lower in the NIC
group and higher in the NS group, and QRA was greater in the
TNG group and lower in the NS group. The SV did not change
after PHE, remaining higher in the NIC group.
The radial artery flow tracing had a biphasic wave form
composed of a systolic and a diastolic wave in all patients.
The diastolic wave was greater than the systolic wave in
both pre-PHE and post-PHE periods (Figure 2).
Discussion
The principal finding of this study is that PHE increased the
blood flow of the T-grafted radial artery. This increase
occurred in all patients irrespective of the presence or ab-
sence of the concurrent infusion of a vasodilator (TNG or
NIC).
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PGraft flow is similar in venous and arterial coronary
bypass grafts when there is occlusion or severe coronary
stenosis and is primarily related to the size of the outflow
bed (amount of viable myocardium). Arterial conduit flow
TABLE 1. Demographic data and preoperative medications
NIC (n  9)
Age (y)* 54  8
Sex (F/M) 2/7
Height (cm)* 177 11
Weight (kg)* 99 16
BSA (m2)* 2.2 0.3
-blockers 7
Ca blockers 1
ACE inhibitors 3
Heparin 1
Nitrates 3
Aspirin 8
Hypertension 3
Shortness of breath 2
Congestive heart failure 0
Angina 6
Diabetes mellitus 3
Cerebrovascular disease 2
Smoking 1
Myocardial infarction 5
LVEDP (mm Hg)* 18 5
EF (%)* 45  10
LV score* 8.3 2.6
NIC, Nicardipine; NS, normal saline; TNG, nitroglycerin; BSA, body surface
pressure (data for 17 patients: 6 in the nicardipine group, 6 in the normal
patients: 7 in the nicardipine group, 8 in the normal saline group, and 8 in
TABLE 2. Angiographic data and bypass grafts
NIC (n  9)
LAD disease
Obstruction (%)* 82 15
No. of distal anastomoses 11
No. of grafts: ITA/RA 9/2
Circumflex disease
Obstruction (%)* 73 29
No. of distal anastomoses: RA 10
Right coronary disease
Obstruction (%)* 88 17
No. of distal anastomoses: RA 8
Distal anastomosis
Total 29
No. of LITA/RA 9/20
Collateral circulation
Absent/R¡L/R¢L 5/2/2
CBP duration (min)* 127 33
AXC duration (min)* 108 32
NIC, Nicardipine; NS, normal saline; TNG, nitroglycerin; LAD, left anterior d
left internal thoracic artery; R¡L, right to left; R¢L, left to right; CBP, cardiop
The Journal of Thoraciwill be less if there is competitive coronary flow usually
caused by a less severe coronary stenosis or occasionally
abundant collateral flow because of the similarity in diam-
eter of the coronary and conduit arteries and the greater
S (n  10) TNG (n  11) P value
60 8 58  10 .46
4/6 2/9 .59
171 10 166 27 .39
85 18 97 29 .35
1.9 0.2 2.0 0.2 .19
5 5 .34
1 4 .31
2 3 .88
3 1 .47
2 3 .88
8 9 1.0
4 8 .22
4 4 .71
3 0 .06
8 10 .77
2 2 .76
0 2 .42
2 5 .23
4 3 .39
15 5 14  5 .38
52 8 47  15 .39
6.3 1.6 6.6 2.3 .12
ACE, angiotensin-converting enzyme; LVEDP, left ventricular end-diastolic
group, and 5 in the nitroglycerin group); EF, ejection fraction (data for 23
nitroglycerin group); LV score, left ventricular score. *Mean  SD.
NS (n  10) TNG (n  11) P value
77 28 70  24 .55
13 19 .44
10/3 16/3 .27/.95
79 17 74  29 .86
14 15 .68
81 29 72  19 .40
9 9 .95
36 43 .41
10/26 16/27 .27/.41
7/1/2 10/0/1 .40
142 49 140  26 .63
111 15 121  27 .51
ding coronary artery; ITA, internal thoracic artery; RA, radial artery; LITA,N
area;
salineescen
ulmonary bypass; AXC, aortic crossclamp. *Mean  SD.
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CSPlength of the conduit with correspondingly greater resis-
tance to flow. This phenomenon does not usually prevail
with vein grafts because of their much greater diameter and
therefore flow capacity because the primary resistance to
TABLE 3. Hemodynamics
NIC (n  9)
Pre-PHE Post-PHE
MAP (mm Hg) 76 6 95  9*
%  MAP 25 7 28  15
QRA (mL/min) 113 60 149 77*
%  QRA 37  27 40  25
SVR (dyne sec · cm5) 947 275 1245 382†
%  SVR 32  18 33  18
HR (beats/min) 92 4 91  4
CVP (mm Hg) 8 4 8  4
PAM (mm Hg) 20 4 22  5
PCWP (mm Hg) 10 3 10  4
SV (mL) 67 20 66  18
All data are presented as means  SD. NIC, Nicardipine; NS, normal sali
radial artery graft flow; SVR, systemic vascular resistance; HR, heart rate
pulmonary capillary wedge pressure; SV, stroke volume. *P  .001 versu
Figure 1. Radial artery flow at control (pre) and after in
each patient in the 3 groups: nicardipine (NIC), norm
summarizes the percentage increase in flow for each
but not between groups. QRA, Radial artery flow; PHE, p
flow.
690 The Journal of Thoracic and Cardiovascular Surgery ● Septflow is the cross-sectional area of lumen according to the
Poiseuille equation.
Baseline (pre-PHE) radial artery flow was similar in the
saline-treated patients to that measured in 200 patients (88
NS (n  10) TNG (n  11)
Pre-PHE Post-PHE Pre-PHE Post-PHE
79 9 100 10* 82 7 108  10*
31 11
93 49 132 68* 132 68 182  83*
48 36
81 828 2005 1183† 1296 273 1719  256†
36 25
93  5 93  6 94  7 93  8
8  3 8  3 10  3 10  3
20  6 21  6 22  5 23  6
10  4 12  7 12  4 14  5
50 17 50  21 50 10 50  10
NG, nitroglycerin; PHE, phenylephrine; MAP, mean arterial pressure; QRA,
central venous pressure; PAM, mean pulmonary artery pressure; PCWP,
PHE. †P  .003 versus pre-PHE.
sing mean arterial pressure 20% (post) is depicted for
line (NS), and nitroglycerin (TNG). Lower right panel
, which was significant within each group (P < .001)
lephrine; % QRA, percentage change in radial artery14
ne; T
; CVP,crea
al sa
group
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P 49 mL/min; MAP, 80  10 mm Hg).8 Graft flow was
greater in the patients receiving NIC or TNG both before
PHE and after PHE, but this did not achieve significance
compared with the NS-treated patients. These agents could
have dilated the conduit and the coronary vessels. However,
the primary determinant of conduit flow, assuming there is
no significant competitive flow, is the resistance of the
coronary vascular bed, unless there is conduit spasm. A
decrease in conduit diameter to less than its usual or optimal
diameter could reduce conduit flow, and this has been a
concern over the use of vasoconstrictors in the postbypass
interval and was the primary reason for this study. Because
we did not measure conduit diameter, we cannot exclude a
PHE effect. Likewise, we cannot conclude that conduit
diameter did not increase because of flow-mediated vasodi-
latation as MAP and conduit flow increased (after PHE). In
another series from our center, we have found that radial
artery free flow in the T-graft configuration was 161  81
mL/min (n  200) at a MAP of 78  9 mm Hg,8 which was
less than the 182  83 mL/min measured in the TNG group
after PHE in the current study. This would suggest that TNG
might have caused an increase in the grafted radial artery
diameter, flow-mediated vasodilation took place, or both.
An additional concern is the anastomosis of the radial
artery to the internal thoracic artery, suggesting that flow
through the T-graft might be limited by the proximal seg-
Figure 2. These are typical tracings from a patient rec
phenylephrine (PHE). From top to bottom are electrocar
wave; D, diastolic wave), arterial pressure (ART), pulmo
venous pressure (CVP). Similar tracings were recordement of the internal thoracic artery. We have shown that the
The Journal of Thoracitotal T-graft free flow (both ends measured simultaneously)
was 26% 14% less than the sum of each component’s free
flow (226  84 mL/min vs 298  101 mL/min, both at a
MAP of 79 mm Hg).8 Although the T-graft configuration
can potentially limit total flow, experience indicates that the
internal thoracic artery is not vulnerable to clinical use of
vasoconstricting agents. Thus, on the basis of its known
propensity for vasoconstriction, the radial artery becomes
the potential flow-limiting component of the T-graft. Our
observations indicate that PHE does not elicit this potential;
however, that might not necessarily apply to other
vasoconstrictors.
The flow pattern in the radial artery was similar before
and after PHE and consisted of a small systolic wave and a
wider, higher diastolic wave (Figure 2). This pattern is
typical of the flow wave in the coronary artery or bypass
grafts on the left side of the heart, as opposed to those
supplying the right ventricle, where the systolic wave is
greater and the diastolic component is reduced.9 Restricted
inflow results in flattening of the flow waves, and increased
coronary vascular resistance prevents an increase in or
could decrease radial artery flow, neither of which occurred
after PHE.
We believe that our harvesting technique with clipping
or ultrasonic coagulation of the radial artery branches and
gentle traction on the radial artery results in minimal trauma
g nicardipine before (pre) and after (post) infusion of
am (ECG), transonic radial artery (RA) flow (S, systolic
artery pressure (PA), wedge (W) pressure, and central
m all patients.eivin
diogr
nary
d froto the conduit. In addition, the radial artery is maintained in
c and Cardiovascular Surgery ● Volume 130, Number 3 691
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anastomosis is performed, followed by exposure of the
conduits to arterial pressure in the presence of intraluminal
papaverine. Atraumatic harvesting of the radial artery en-
sures excellent endothelial preservation and function, with
basal production of nitric oxide, as well as flow-mediated
shear stress–stimulated nitric oxide release.
The small number of subjects is one of the limitations of
the study. The free QRA depends on perfusion pressure,
lumen area, and endothelial function, whereas the QRA
depends additionally on the technique used to measure it
(eg, electromagnetic vs transonic flowmeters and calibra-
tion). Assuming a QRA of 100 to 110 mL/min with a
standard deviation of 50 to 60 mL/min, a sample size of 8
patients per group would have been adequate to show a 20%
increase in QRA, excluding an  error of .05. The study was
not designed to evaluate differences of QRA on the basis of
the administration of a vasodilator. However, there was no
statistical difference between the groups regarding the mag-
nitude of QRA increase. We did not examine the reactivity of
the radial artery to PHE either in the forearm (in situ) or as
a conduit. The purpose of the study was to investigate the
clinical effects of PHE on QRA, as measured with the
flowmeter and demonstrated by the common clinical mon-
itoring devices.
We have not found it necessary to use vasodilating drugs
either in the perioperative interval or systemically after-692 The Journal of Thoracic and Cardiovascular Surgery ● Septing drugs in patients receiving all arterial coronary revas-
cularization because we believe that adequate blood
pressure is required to maintain arterial conduit flow.
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